NASDAQ:RANI | Free Cash Flow | Rani Therapeutics Holdings, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2020-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$6.5M$15,000.00-$6.51M
2025-12-31$294,000.00$0.00$294,000.00
2025-03-31-$8.15M$51,000.00-$8.2M
2024-12-31-$8.66M$31,000.00-$8.69M
2024-03-31-$9.4M$18,000.00-$9.42M
2023-12-31-$12.48M$167,000.00-$12.65M
2023-03-31-$12.15M$248,000.00-$12.4M
2022-12-31-$14.63M$530,000.00-$15.16M
2022-03-31-$9.36M$254,000.00-$9.61M
2021-12-31-$11.45M$271,000.00-$11.72M
2021-03-31-$4.05M$99,000.00-$4.15M
2020-12-31-$6.7M$256,000.00-$6.96M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$18.71M$88,000.00-$18.8M
2024-12-31-$35.5M$268,000.00-$35.76M
2023-12-31-$51.24M$1.23M-$52.47M
2022-12-31-$46.52M$1.62M-$48.13M
2021-12-31-$32.25M$506,000.00-$32.75M
2020-12-31-$14.96M$1.2M-$16.16M